Genie OMalley - Drug Free Pres, Founder
| DSOL Stock | USD 0.0002 0.00 0.00% |
Founder
Genie OMalley is Pres, Founder of Drug Free Solution since 2019.
| Age | 53 |
| Tenure | 6 years |
| Phone | 888-615-6122 |
| Web | https://www.drugfreesolution.com |
Drug Free Management Efficiency
The company has return on total asset (ROA) of (12.7007) % which means that it has lost $12.7007 on every $100 spent on assets. This is way below average. Drug Free's management efficiency ratios could be used to measure how well Drug Free manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | FOUNDER Age | ||
| Michael Kirban | Vita Coco | 50 | |
Management Performance
| Return On Asset | -12.7 |
Drug Free Solution Leadership Team
Elected by the shareholders, the Drug Free's board of directors comprises two types of representatives: Drug Free inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Drug. The board's role is to monitor Drug Free's management team and ensure that shareholders' interests are well served. Drug Free's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Drug Free's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Genie OMalley, Pres, Founder | ||
| Jessica Bass, Chief Officer |
Drug Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Drug Free a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -12.7 | |||
| Operating Margin | (413.00) % | |||
| Current Valuation | 496.08 K | |||
| Shares Outstanding | 35.94 M | |||
| Price To Earning | (1.56) X | |||
| Price To Sales | 239.51 X | |||
| Gross Profit | (171.22 K) | |||
| EBITDA | (862.83 K) | |||
| Net Income | (755.87 K) | |||
| Cash And Equivalents | 7.12 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Drug Pink Sheet
Drug Free financial ratios help investors to determine whether Drug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Drug with respect to the benefits of owning Drug Free security.